H-1B Visa: US Innovation at Risk in 2026
Is the H-1B visa program failing US innovation? Learn why current caps and processing times stifle growth in AI and biotech.
Is the H-1B visa program failing US innovation? Learn why current caps and processing times stifle growth in AI and biotech.
Why don't life-saving vaccines reach everyone? Learn how private profit and public funding create disparities and what 2026 reforms can do.
Over $10 billion in Section 301 tariff refunds remain unclaimed. See why businesses miss out and how to recover lost capital.
H-1B visas drive local economic growth. See how skilled workers create jobs, boost tax revenue, and fuel innovation in US communities by 2026.
US faces 2026 workforce gaps. Can immigration reform, like expanding H-2B visas, fill 1.5M jobs and boost GDP by 0.5%? Find out how.
Understand 5 H-1B enforcement risks employers face by 2026. Learn how to avoid penalties and operational disruptions with compliance strategies.
Drug price cuts hit pharma in 2026. How will the IRA and other pressures reshape R&D and market access? See what's next for drug innovation.
How will the Cape Fear Bridge be paid for? Learn about infrastructure bonds, global examples like the Øresund Bridge, and what it means for Wilmington.
Only 15% of nations regulate quantum ethics. See why the UN wants a global treaty by 2026 and how countries like China are responding.
H-1B employers face rising scrutiny. Learn about $12M in back wages, increased RFEs, and new rules impacting 2024 compliance risks.